Remembering Prof Liu Chuntian, a scholar and dear friend.
The NTE Report On Chinese IP And Its Relationships To Chinese Legal Developments
USTR’s recently released NTE report shows continuing lack of clarity over key Chinese legal terms. The report also declines to discuss commercial rule of law issues raised in last years Special 301 report. What role does commercial rule of law have in the Biden Administration’s trade diplomacy? The answer is unclear.
Recent Recordings and Upcoming Programs
Here is a listing of recordings of some recent programs that are now available as well as a listing of upcoming events. The Third Berkeley-Tsinghua Conference on Transnational IP Litigation was held […]
Berkeley-Tsinghua Transnational IP Litigation Program Launches Soon
Berkeley and Tsinghua Law will co-host their third annual program on transnational IP litigation, focusing on the impact of the trade war on settlement of IP disputes.
Upcoming Federalist Society Live Podcast on China IP
I will be talking at a Federalist Society sponsored live podcast this Thursday October 22, 2020 at noon EDT on “The United States-China Relationship and Intellectual Property”. My fellow speakers are two […]
Fact and Fiction in the US-China IP Trade War
The Asia Society of Northern California is sponsoring a free webinar October 8 from 5-6:30 PM PST on “Fact and Fiction in the US-China IP Trade War” as part of its “Seek […]
Antitrust Aspects of “Unfairly High Patent Pricing” for Licensing Transactions in China
This guest blog has been written by Prof. HAO Yuan of Tsinghua University School of Law. China is facing a pressing need to build its innovation-driven economy. To facilitate key features of […]
Second Annual Berkeley-Tsinghua Transnational IP Litigation Conference Is Fast Approaching
Berkeley Law and Tsinghua law will be co-hosting their Second Annual Conference on Transnational IP Litigation, at the campus of UC Berkeley on October 22, 2019. Details, including registration information, are available here. […]
China’s “Naked Bolar” and the Tapering Momentum to Protect Innovative Pharmaceuticals
There have been several important developments in recent weeks involving pharmaceutical IP protection in both mainland China and Taiwan. Based on these developments, mainland China appears to be slowing its momentum to […]
Collaboration or Confrontation: Beyond the False Dichotomy in US-China IP Relations
Recently several writers have criticized the Trump administration’s strategic choice of confrontation over collaboration with China. Among them was an open letter published in the July 2, 2019, Washington Post, “China is Not […]